News
WuXi Biologics Ireland facility receives EMA approval for commercial manufacturing of innovative biologic: Dundalk, Ireland Tuesday, August 19, 2025, 12:00 Hrs [IST] WuXi Biologic ...
Valneva’s chikungunya vaccine, Ixchiq receives Health Canada marketing authorization: Saint Herblain, France Tuesday, August 19, 2025, 10:00 Hrs [IST] Valneva SE, a specialty va ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
US FDA grants breakthrough therapy designation to Daiichi Sankyo & Merck’s ifinatamab deruxtecan for patients with pretreated extensivestage SCLC: Tokyo Tuesday, August 19, 2025 ...
Future of Indian healthcare revolves around proactive, tech-driven & people-centric systems: Lovekesh Phasu: Nandita Vijayasimha, Bengaluru Tuesday, August 19, 2025, 08:00 Hrs [IS ...
Delhi DCA issues advisory to chemist associations on misuse of pregabalin & tapentadol formulations: Peethaambaran Kunnathoor, Chennai Tuesday, August 19, 2025, 08:00 Hrs [IST] In ...
Exports of drugs and pharmaceuticals from the country registered around 14 per cent growth in the month of July, while imports reported an increase of around 13.3 per cent compared to the same month ...
Caris Life Sciences demonstrates scientific rigor with clinical validation of US FDA approved MI Cancer Seek: Irving, Texas Monday, August 18, 2025, 16:00 Hrs [IST] Caris Life Sci ...
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
Livlong 365 OPD healthtech platform to invest Rs. 100 crore in major offline expansion, targets 100 branches by 2027: Our Bureau, Bengaluru Monday, August 18, 2025, 17:15 Hrs [IST ...
CPTx & NanoCell Therapeutics project receives EU funding for innovative in vivo CAR T therapy with immune-silent single-stranded DNA: Munich, Germany Monday, August 18, 2025, 15:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results